10.01.2015 Views

Download PDF version English(2664KB) - Hamon

Download PDF version English(2664KB) - Hamon

Download PDF version English(2664KB) - Hamon

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Part 3 - Financial Statements<br />

65<br />

Financial Assets and Liabilities<br />

Financial assets or liabilities are recognized on the<br />

balance sheet at the date of the transaction, which<br />

corresponds to the date on which the entity contractually<br />

commits to buy or sell an asset.<br />

When a financial asset or financial liability is recognized<br />

initially, it is measured at its fair value plus (in case of<br />

financial asset) or minus (in case of financial liability)<br />

transaction costs except for financial assets at fair value<br />

through income statement.<br />

Fair value is defined as the amount for which an asset<br />

could be exchanged or a liability settled between<br />

knowledgeable willing parties in an arm’s length<br />

transaction. Fair value of a financial liability will be for<br />

instance, the cash received from the lenders when the<br />

liability is issued.<br />

There are four categories of financial assets:<br />

■ Financial assets at fair value through profit or loss<br />

(designated by the entity or classified as held for<br />

trading);<br />

■ Held-to-maturity investments;<br />

■ Loans and receivables;<br />

■ Available-for-sale financial assets.<br />

There are two categories of financial liabilities:<br />

■ Financial liabilities at fair value through profit or loss;<br />

■ Other financial liabilities measured at amortized cost.<br />

Subsequently,<br />

the fair value changes in financial assets and liabilities<br />

at fair value through profit or loss are recognized<br />

through the income statement.<br />

the fair value changes in available-for-sale-assets are<br />

recognized directly in the equity until the asset is sold<br />

or is identified as impaired. Then the cumulative gain/<br />

loss that had been recognized in equity shall be<br />

removed and recognized in income statement.<br />

investments in equity instruments that are not quoted<br />

in an active market and whose fair value cannot be<br />

reliably measured by an alternative pricing method are<br />

evaluated at cost.<br />

loans and receivables, held-to-maturity Investments<br />

and other financial liabilities are measured at amortized<br />

cost using the effective interest rate method, except<br />

for fixed term/time deposits, which are valued at cost.<br />

The effective interest rate is the rate that exactly<br />

discounts estimated future net cash settlements or<br />

receipts through the expected life of the financial asset<br />

or liability to its net carrying amount.<br />

Trade and Other Receivables (Payables)<br />

Receivables and payables are recognized using the<br />

amortized cost method i.e. the discounted value of the<br />

receivable. Appropriate impairment losses are recognized<br />

on receivables in case of expected default of payments.<br />

Cash and Cash Equivalents<br />

Cash and cash equivalents comprise cash on hand and<br />

demand deposits together with short-term, highly liquid<br />

investments, that are readily convertible into a known<br />

amount of cash, that have a maturity of three months<br />

or less, and that are subject to an insignificant risk of<br />

change in value. These elements are taken into the<br />

Balance Sheet at their nominal value. Bank overdrafts<br />

are included in the current financial liabilities.<br />

Equity Instruments<br />

Any contract that evidences a residual interest in the<br />

assets of an entity after deducting all of its liabilities is<br />

an equity instrument. Equity instruments issued by the<br />

Company are measured at their fair value net of<br />

issuance costs.<br />

Loans & borrowings<br />

Loans and borrowings are initially recognized at fair<br />

value, plus or minus transaction costs. They are<br />

subsequently measured at amortized cost using the<br />

effective interest method. Any subsequent change in<br />

value between the fair value and the settlement value<br />

(including the redemption premium to be received or<br />

paid) is recognized in the income statement over the<br />

period of the borrowing (effective interest rate method).<br />

The borrowing issuance costs related to mixed facilities<br />

including debt and bank guarantee lines agreement<br />

are prorated between the different lines and presented<br />

in deduction of the financial liabilities on the balance<br />

sheet.<br />

Amounts borrowed as part of the “Credit Revolving<br />

Facility” are accounted for under ‘Non-current Financial<br />

Liabilities’ when the maturity of those borrowing are<br />

above one year and the Group has the possibility to<br />

roll-over them at its discretion.<br />

Derivative Financial Instruments<br />

The Group enters into derivative financial instruments to<br />

manage its exposure to interest rate risks arising from<br />

financing activities and foreign exchange rate risks<br />

arising from operational activities (cash flow hedges).<br />

The Group’s policy is not to enter into speculative<br />

transactions nor issue or hold financial instruments for<br />

negotiation purposes.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!